Z-1636-2026 Class II Ongoing
FDA device recall Z-1636-2026 was initiated by Tandem Diabetes Care, Inc. on January 30, 2026 and is designated Class II. Reason for recall: The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when … The recall status is ongoing. Affected quantity: 1,380 units.
Recall Details
- Product Type
- Devices
- Report Date
- April 1, 2026
- Initiation Date
- January 30, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,380 units
Product Description
Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient).
Reason for Recall
The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event.
Distribution Pattern
International distribution in the countries of Czech Republic, Slovakia.
Code Information
Version 7.8.1/ UDI: (01)008500066132625